Professional
Added to YB: 2024-08-13
Pitch date: 2024-07-01
CAMX.ST [bullish]
Camurus AB (publ)
+2.69%
current return
Author Info
No bio for this author
Company Info
Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.
Market Cap
SEK 39.0B
Pitch Price
SEK 595.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
141.93
P/E
174.23
EV/Sales
22.89
Sector
Pharmaceuticals
Category
value
Protean Funds Scandinavia AB Portfolio Holding: Camurus AB
CAMX.ST: Buvidal/Brixadi franchise expanding; long-release tech platform w/ potential in multiple fields, esp. acromegaly. Recent main owner sell-down created entry opportunity. Transitioning from single-product to multi-application company. Strong growth potential in pharmaceutical tech space.
Read full article (1 min)